XIMENCY Trademark

Trademark Overview

On Monday, October 23, 2017, a trademark application was filed for XIMENCY with the United States Patent and Trademark Office. The USPTO has given the XIMENCY trademark a serial number of 87656218. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 20, 2022. This trademark is owned by Bristol-Myers Squibb Company. The XIMENCY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
ximency

General Information

Serial Number87656218
Word MarkXIMENCY
Filing DateMonday, October 23, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2021SOU EXTENSION 5 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 5 FILED
Monday, October 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021SOU EXTENSION 4 GRANTED
Friday, April 23, 2021SOU EXTENSION 4 FILED
Friday, April 23, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 12, 2020SOU EXTENSION 3 GRANTED
Thursday, November 12, 2020SOU EXTENSION 3 FILED
Thursday, November 12, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020SOU EXTENSION 2 GRANTED
Wednesday, May 13, 2020SOU EXTENSION 2 FILED
Wednesday, May 13, 2020SOU TEAS EXTENSION RECEIVED
Friday, November 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 30, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 30, 2019SOU EXTENSION 1 FILED
Wednesday, October 30, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 4, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, October 24, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 23, 2018ASSIGNED TO LIE
Friday, August 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2018NON-FINAL ACTION WRITTEN
Wednesday, January 31, 2018ASSIGNED TO EXAMINER
Wednesday, November 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 26, 2017NEW APPLICATION ENTERED

Related Keywords

ximency diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection